26582989|t|HDL and glucose metabolism: current evidence and therapeutic potential.
26582989|a|High-density lipoprotein (HDL) and its principal apolipoprotein A-I (ApoA-I) have now been convincingly shown to influence glucose metabolism through multiple mechanisms. The key clinically relevant observations are that both acute HDL elevation via short-term reconstituted HDL (rHDL) infusion and chronically raising HDL via a cholesteryl ester transfer protein (CETP) inhibitor reduce blood glucose in individuals with type 2 diabetes mellitus (T2DM). HDL may mediate effects on glucose metabolism through actions in multiple organs (e.g., pancreas, skeletal muscle, heart, adipose, liver, brain) by three distinct mechanisms: (i) Insulin secretion from pancreatic beta cells, (ii) Insulin-independent glucose uptake, (iii) Insulin sensitivity. The molecular mechanisms appear to involve both direct HDL signaling actions as well as effects secondary to lipid removal from cells. The implications of glucoregulatory mechanisms linked to HDL extend from glycemic control to potential anti-ischemic actions via increased tissue glucose uptake and utilization. Such effects not only have implications for the prevention and management of diabetes, but also for ischemic vascular diseases including angina pectoris, intermittent claudication, cerebral ischemia and even some forms of dementia. This review will discuss the growing evidence for a role of HDL in glucose metabolism and outline related potential for HDL therapies. 
26582989	8	15	glucose	Chemical	MESH:D005947
26582989	121	139	apolipoprotein A-I	Gene	335
26582989	141	147	ApoA-I	Gene	335
26582989	195	202	glucose	Chemical	MESH:D005947
26582989	401	435	cholesteryl ester transfer protein	Gene	1071
26582989	437	441	CETP	Gene	1071
26582989	460	473	blood glucose	Chemical	MESH:D001786
26582989	494	518	type 2 diabetes mellitus	Disease	MESH:D003924
26582989	520	524	T2DM	Disease	MESH:D003924
26582989	554	561	glucose	Chemical	MESH:D005947
26582989	706	713	Insulin	Gene	3630
26582989	757	764	Insulin	Gene	3630
26582989	777	784	glucose	Chemical	MESH:D005947
26582989	799	806	Insulin	Gene	3630
26582989	929	934	lipid	Chemical	MESH:D008055
26582989	1063	1071	ischemic	Disease	MESH:D002545
26582989	1101	1108	glucose	Chemical	MESH:D005947
26582989	1210	1218	diabetes	Disease	MESH:D003920
26582989	1233	1259	ischemic vascular diseases	Disease	MESH:D014652
26582989	1270	1285	angina pectoris	Disease	MESH:D000787
26582989	1287	1312	intermittent claudication	Disease	MESH:D007383
26582989	1314	1331	cerebral ischemia	Disease	MESH:D002545
26582989	1355	1363	dementia	Disease	MESH:D003704
26582989	1432	1439	glucose	Chemical	MESH:D005947
26582989	Positive_Correlation	MESH:D005947	MESH:D002545
26582989	Association	MESH:D005947	335
26582989	Association	MESH:D001786	MESH:D003924
26582989	Association	MESH:D003924	1071

